2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026

The metabolic syndrome—a new worldwide definition

Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490

Health benefits of physical activity: the evidence

Warburton, D. E. R. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051351 · Cited by 8,007

General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS

Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938

Exercise capacity and mortality among men referred for exercise testing

Myers, J., Prakash, M., Froelicher, V., Do, D., Partington, S., & Atwood, J. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011858 · Cited by 4,114

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641

ESC/EAS Guidelines for the management of dyslipidaemias

Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549

Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489

PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439

Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups

Detrano, R., Guerci, A. D., Carr, J. J., Bild, D. E., Burke, G., Folsom, A. R., Liu, K., Shea, S., Szklo, M., Bluemke, D. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa072100 · Cited by 2,989

Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis

Lorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M., & Sitzer, M. (2007) · Circulation · doi:10.1161/circulationaha.106.628875 · Cited by 2,977

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

Collaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2010) · The Lancet · doi:10.1016/s0140-6736(09)61717-7 · Cited by 2,546

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine

WRITING GROUP MEMBERS, Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d4739e · Cited by 2,289

Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study

Wen, C. P., Wai, J. P. M., Tsai, M. K., Yang, Y. C., Cheng, T. Y. D., Lee, M.-C., Chan, H. T., Tsao, C. K., Tsai, S. P., & Wu, X. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60749-6 · Cited by 1,908

Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality: A Meta-analysis

(2008) · JAMA · doi:10.1001/jama.300.2.197 · Cited by 1,874

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Writing Committee Members, Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,873

Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals

Greenland, P. (2004) · JAMA · doi:10.1001/jama.291.2.210 · Cited by 1,829

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality

(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753

Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease

Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671

High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction<SUBTITLE>The IDEAL Study: A Randomized Controlled Trial</SUBTITLE>

Pedersen, T. R. (2005) · JAMA · doi:10.1001/jama.294.19.2437 · Cited by 1,548

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521

Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction

Kamstrup, P. R. (2009) · JAMA · doi:10.1001/jama.2009.801 · Cited by 1,357

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.001 · Cited by 1,324

New Canadian Physical Activity Guidelines

Tremblay, M. S., Warburton, D. E. R., Janssen, I., Paterson, D. H., Latimer, A. E., Rhodes, R. E., Kho, M. E., Hicks, A., LeBlanc, A. G., Zehr, L., et al. (2011) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h11-009 · Cited by 1,238

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals

Yeboah, J., McClelland, R. L., Polonsky, T. S., Burke, G. L., Sibley, C. T., O’Leary, D., Carr, J. J., Goff, D. C., Greenland, P., & Herrington, D. M. (2012) · JAMA · doi:10.1001/jama.2012.9624 · Cited by 1,122

Coronary Artery Calcium Score and Risk Classification for Coronary Heart Disease Prediction

Polonsky, T. S. (2010) · JAMA · doi:10.1001/jama.2010.461 · Cited by 1,119

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

Jackevicius, C. A. (2002) · JAMA · doi:10.1001/jama.288.4.462 · Cited by 1,077

Association of Hemoglobin A 1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk

Khaw, K.-T., Wareham, N., Bingham, S., Luben, R., Welch, A., & Day, N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00006 · Cited by 974

ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain

Greenland, P., Bonow, R. O., Brundage, B. H., Budoff, M. J., Eisenberg, M. J., Grundy, S. M., Lauer, M. S., Post, W. S., Raggi, P., Redberg, R. F., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.001 · Cited by 962

Carotid Intima-Media Thickness and Presence or Absence of Plaque Improves Prediction of Coronary Heart Disease Risk

Nambi, V., Chambless, L., Folsom, A. R., He, M., Hu, Y., Mosley, T., Volcik, K., Boerwinkle, E., & Ballantyne, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.075 · Cited by 919

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863

Genetically elevated C-reactive protein and ischemic vascular disease

Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707402 · Cited by 839

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

Ridker, P. M., Pradhan, A., MacFadyen, J. G., Libby, P., & Glynn, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61190-8 · Cited by 816

Parental Cardiovascular Disease as a Risk Factor for Cardiovascular Disease in Middle-aged Adults: A Prospective Study of Parents and Offspring

Lloyd-Jones, D. M., Nam, B.-H., D'Agostino, Sr., Levy, D., Murabito, J. M., Wang, T. J., Wilson, P. W. F., & O'Donnell, C. J. (2004) · JAMA · doi:10.1001/jama.291.18.2204 · Cited by 807

Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis

Boekholdt, S. M., Arsenault, B. J., Mora, S., Pedersen, T. R., LaRosa, J. C., Nestel, P. J., Simes, R. J., Durrington, P., Hitman, G. A., Welch, K. M. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.366 · Cited by 795

Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis

Erbel, R., Möhlenkamp, S., Moebus, S., Schmermund, A., Lehmann, N., Stang, A., Dragano, N., Grönemeyer, D., Seibel, R., Kälsch, H., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.030 · Cited by 771

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations

Genest, J., McPherson, R., Frohlich, J., Anderson, T., Campbell, N., Carpentier, A., Couture, P., Dufour, R., Fodor, G., Francis, G. A., et al. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70715-9 · Cited by 768

Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction: A Meta-analysis

Den Ruijter, H. M., Peters, S. A. E., Anderson, T. J., Britton, A. R., Dekker, J. M., Eijkemans, M. J., Engström, G., Evans, G. W., de Graaf, J., Grobbee, D. E., et al. (2012) · JAMA · doi:10.1001/jama.2012.9630 · Cited by 760

Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Han, C., Robinson, D., Hackett, M., Paramore, L. C., Fraeman, K. H., & BALA, M. M. (2006) · PubMed · Cited by 721

Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study

Tonelli, M., Muntner, P., Lloyd, A., Manns, B. J., Klarenbach, S., Pannu, N., James, M. T., & Hemmelgarn, B. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60572-8 · Cited by 718

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.007 · Cited by 691

A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk

Sniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.959247 · Cited by 659

Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection

Bozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., & Louis, T. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022048 · Cited by 625

Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis

Yu-Poth, S., Zhao, G., Etherton, T., Naglak, M., Jonnalagadda, S., & Kris-Etherton, P. M. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.4.632 · Cited by 584

Premature cardiovascular disease in chronic renal failure

Baigent, C., Burbury, K., & Wheeler, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02456-9 · Cited by 581

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial

Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group (2010) · The Lancet · doi:10.1016/s0140-6736(10)60310-8 · Cited by 558

Multiple risk factor interventions for primary prevention of coronary heart disease

Ebrahim, S., Taylor, F., Ward, K., Beswick, A., Burke, M., & Davey Smith, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001561.pub3 · Cited by 546

COPD and Incident Cardiovascular Disease Hospitalizations and Mortality: Kaiser Permanente Medical Care Program

Sidney, S., Sorel, M., Quesenberry, C. P., DeLuise, C., Lanes, S., & Eisner, M. D. (2005) · Chest · doi:10.1378/chest.128.4.2068 · Cited by 540

Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus

Ward, M. M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199902)42:2<338::aid-anr17>3.0.co;2-u · Cited by 529

Physical Activity Recommendations and Decreased Risk of Mortality

Leitzmann, M. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.22.2453 · Cited by 438

Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk

Cooney, M. T., Dudina, A. L., & Graham, I. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.020 · Cited by 436

Coronary Calcium Score Improves Classification of Coronary Heart Disease Risk in the Elderly

Elias-Smale, S. E., Proença, R. V., Koller, M. T., Kavousi, M., van Rooij, F. J. A., Hunink, M. G., Steyerberg, E. W., Hofman, A., Oudkerk, M., & Witteman, J. C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.029 · Cited by 369

Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study

Peters, M. J. L., van Halm, V. P., Voskuyl, A. E., Smulders, Y. M., Boers, M., Lems, W. F., Visser, M., Stehouwer, C. D. A., Dekker, J. M., Nijpels, G., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24836 · Cited by 368

Coronary Artery Calcium Scores and Risk for Cardiovascular Events in Women Classified as “Low Risk” Based on Framingham Risk Score: The Multi-Ethnic Study of Atherosclerosis (MESA)

Lakoski, S. G. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.22.2437 · Cited by 350

Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study

Blaha, M. J., Budoff, M. J., DeFilippis, A. P., Blankstein, R., Rivera, J. J., Agatston, A., O'Leary, D. H., Lima, J., Blumenthal, R. S., & Nasir, K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60784-8 · Cited by 343

Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin

Waters, D. D., Ho, J. E., DeMicco, D. A., Breazna, A., Arsenault, B. J., Wun, C.-C., Kastelein, J. J., Colhoun, H., & Barter, P. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.047 · Cited by 333

The distribution of 10-Year risk for coronary heart disease among U.S. adults

Ford, E. S., Giles, W. H., & Mokdad, A. H. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.061 · Cited by 330

Increased Small Low-Density Lipoprotein Particle Number: A Prominent Feature of the Metabolic Syndrome in the Framingham Heart Study

Kathiresan, S., Otvos, J. D., Sullivan, L. M., Keyes, M. J., Schaefer, E. J., Wilson, P. W. F., D’Agostino, R. B., Vasan, R. S., & Robins, S. J. (2006) · Circulation · doi:10.1161/circulationaha.105.567107 · Cited by 318

Cardiovascular morbidity in psoriatic arthritis

Gladman, D. D., Ang, M., Su, L., Tom, B. D. M., Schentag, C. T., & Farewell, V. T. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094839 · Cited by 304

Statin Therapy and the Risk of Intracerebral Hemorrhage: A Meta-Analysis of 31 Randomized Controlled Trials

McKinney, J. S., & Kostis, W. J. (2012) · Stroke · doi:10.1161/strokeaha.112.655894 · Cited by 294

Pathogenesis of Thoracic and Abdominal Aortic Aneurysms

GUO, D., PAPKE, C. L., HE, R., & MILEWICZ, D. M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1383.013 · Cited by 280

The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis

Perkovic, V., Verdon, C., Ninomiya, T., Barzi, F., Cass, A., Patel, A., Jardine, M., Gallagher, M., Turnbull, F., Chalmers, J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050207 · Cited by 239

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts

Shah, T., Casas, J. P., Cooper, J. A., Tzoulaki, I., Sofat, R., McCormack, V., Smeeth, L., Deanfield, J. E., Lowe, G. D., Rumley, A., et al. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn217 · Cited by 238

Apparent discontinuation rates in patients prescribed lipid‐lowering drugs

Simons, L. A., Levis, G., & Simons, J. (1996) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1996.tb94138.x · Cited by 214

Chronic Inflammatory Diseases and Cardiovascular Risk: A Systematic Review

Roifman, I., Beck, P. L., Anderson, T. J., Eisenberg, M. J., & Genest, J. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.12.040 · Cited by 214

The Effect of Giving Global Coronary Risk Information to Adults: A Systematic Review

Sheridan, S. L. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.516 · Cited by 208

Detecting Drug Interactions From Adverse-Event Reports: Interaction Between Paroxetine and Pravastatin Increases Blood Glucose Levels

Tatonetti, N. P., Denny, J. C., Murphy, S. N., Fernald, G. H., Krishnan, G., Castro, V, Yue, P., Tsau, P. S., Kohane, I., Roden, D. M., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.83 · Cited by 201

Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program

Aktas, M. K. (2004) · JAMA · doi:10.1001/jama.292.12.1462 · Cited by 193

ESC/EAS Guidelines for the management of dyslipidaemias

Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.012 · Cited by 192

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference

Mancini, G. B. J., Baker, S., Bergeron, J., Fitchett, D., Frohlich, J., Genest, J., Gupta, M., Hegele, R. A., Ng, D., & Pope, J. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.05.007 · Cited by 188

Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study

Grover, S. A., Lowensteyn, I., Esrey, K. L., Steinert, Y., Joseph, L., & Abrahamowicz, M. (1995) · BMJ · doi:10.1136/bmj.310.6985.975 · Cited by 181

Usefulness of Exercise Testing in the Prediction of Coronary Disease Risk Among Asymptomatic Persons as a Function of the Framingham Risk Score

Balady, G. J., Larson, M. G., Vasan, R. S., Leip, E. P., O’Donnell, C. J., & Levy, D. (2004) · Circulation · doi:10.1161/01.cir.0000143226.40607.71 · Cited by 180

Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era

Lazar, L. D., Pletcher, M. J., Coxson, P. G., Bibbins-Domingo, K., & Goldman, L. (2011) · Circulation · doi:10.1161/circulationaha.110.986349 · Cited by 174

Patient Knowledge of Coronary Risk Profile Improves the Effectiveness of Dyslipidemia Therapy: The CHECK-UP Study: A Randomized Controlled Trial

Grover, S. A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.21.2296 · Cited by 166

Selecting Asymptomatic Patients for Coronary Computed Tomography or Electrocardiographic Exercise Testing

Greenland, P., & Gaziano, J. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp023197 · Cited by 133

Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles

Soureti, A., Hurling, R., Murray, P., van Mechelen, W., & Cobain, M. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328337ccd3 · Cited by 132

Prospective Study of Statin Use and Risk of Parkinson Disease

Gao, X., Simon, K. C., Schwarzschild, M. A., & Ascherio, A. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.1060 · Cited by 129

Framingham Risk Score and Alternatives for Prediction of Coronary Heart Disease in Older Adults

Rodondi, N., Locatelli, I., Aujesky, D., Butler, J., Vittinghoff, E., Simonsick, E. M., Satterfield, S., Newman, A. B., Wilson, P. W. F., Pletcher, M. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034287 · Cited by 126

Weighing the benefits of high-dose simvastatin against the risk of myopathy

Egan, A., & Colman, E. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1106689 · Cited by 113

A Tale of Two Trials: A Comparison of the Post–Acute Coronary Syndrome Lipid-Lowering Trials A to Z and PROVE IT–TIMI 22

Wiviott, S. D., de Lemos, J. A., Cannon, C. P., Blazing, M. A., Murphy, S. A., McCabe, C. H., Califf, R. M., & Braunwald, E. (2006) · Circulation · doi:10.1161/circulationaha.105.586347 · Cited by 97

Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)

Vinall, M., & Collins, R. (2009) · MD Conference Express · doi:10.1177/155989770900800804 · Cited by 97

Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians

Shillinglaw, B., Viera, A. J., Edwards, T., Simpson, R. J., & Sheridan, S. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-20 · Cited by 90

Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes

Miner, M. M., Seftel, A. D., Nehra, A. X., Ganz, P., Kloner, R. A., Montorsi, P., Vlachopoulos, C. V., Ramsey, M. M., Sigman, M., Tilkemeier, P. L., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.04.006 · Cited by 90

An Externally Validated Model for Predicting Long-Term Survival after Exercise Treadmill Testing in Patients with Suspected Coronary Artery Disease and a Normal Electrocardiogram

Lauer, M. S., Pothier, C. E., Magid, D. J., Smith, S. S., & Kattan, M. W. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-12-200712180-00001 · Cited by 88

Vitamin D deficiency, myositis–myalgia, and reversible statin intolerance

Glueck, C. J., Budhani, S., Masineni, S. S., Abuchaibe, C., Khan, N., Wang, P., & Goldenberg, N. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.598144 · Cited by 82

Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance

Moutzouri, E., Liberopoulos, E. N., Mikhailidis, D. P., Kostapanos, M. S., Kei, A. A., Milionis, H. J., & Elisaf, M. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02779.x · Cited by 76

Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary)

Leiter, L. A., FITCHETT, D. H., Gilbert, R. E., Gupta, M., Mancini, G. B. J., McFarlane, P. A., Ross, R., Teoh, H., Verma, S., Anand, S. S., et al. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.01.016 · Cited by 72

Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative

Tobe, S. W., Stone, J. A., Brouwers, M. C., Bhattacharyya, O. K., Walker, K. M., Dawes, M. G., Genest, J. J., Grover, S. A., Gubitz, G. J., Lau, D. C. W., et al. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101508 · Cited by 69

Effects of Maximal Atorvastatin and Rosuvastatin Treatment on Markers of Glucose Homeostasis and Inflammation

Thongtang, N., Ai, M., Otokozawa, S., Himbergen, T. V., Asztalos, B. F., Nakajima, K., Stein, E. A., Jones, P. H., & Schaefer, E. J. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.09.031 · Cited by 68

Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease

Thompson, G. R., Hollyer, J., & Waters, D. D. (1995) · Current Opinion in Lipidology · doi:10.1097/00041433-199512000-00010 · Cited by 62

Statin Use and Risk of Depression in Patients With Coronary Heart Disease: Longitudinal Data From the Heart and Soul Study

Otte, C., Zhao, S., & Whooley, M. A. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07038 · Cited by 61

Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68–102: The cardiovascular Health Study

Cao, J. J., Biggs, M. L., Barzilay, J. I., KONEN, J. C., Psaty, B. M., Kuller, L. H., Bleyer, A. J., Olson, J., Wexler, J. A., Summerson, J. H., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.029 · Cited by 55

Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus

Thorburn, C. M., & Ward, M. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11241 · Cited by 54

Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance

Kennedy, S. P., Barnas, G. P., Schmidt, M. J., Glisczinski, M. S., & Paniagua, A. C. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.03.454 · Cited by 53

Perceptions of Canadian Primary Care Physicians Towards Cardiovascular Risk Assessment and Lipid Management

Gupta, M., Singh, N., Tsigoulis, M., Kajil, M., Hirjikaka, S., Quan, A., Teoh, H., & Verma, S. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.09.014 · Cited by 43

Statin Use and the Risk of Incident Diabetes Mellitus: A Review of the Literature

Colbert, J. D., & Stone, J. A. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.03.021 · Cited by 37

Preventing cardiovascular disease among Canadians: What are the potential benefits of treating hypertension or dyslipidemia?

Grover, S. A., Coupal, L., Kaouache, M., & Lowensteyn, I. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70786-9 · Cited by 29

Discussing Coronary Risk with Patients to Improve Blood Pressure Treatment: Secondary Results from the CHECK-UP Study

Grover, S. A., Lowensteyn, I., Joseph, L., Kaouache, M., Marchand, S., Coupal, L., & Boudreau, G. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0825-4 · Cited by 28

Life Expectancy Following Dietary Modification or Smoking Cessation: Estimating the Benefits of a Prudent Lifestyle

Grover, S. A., Gray-Donald, K., Joseph, L., Abrahamowicz, M., & Coupal, L. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420150063006 · Cited by 24

Combined cardiovascular and diabetes risk assessment in primary care

Preiss, D., Khunti, K., & Sattar, N. A. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03157.x · Cited by 14

The Effect of the Change in the Framingham Risk Score Calculator Between the 2006 and 2009 Canadian Lipid Guidelines

Armstrong, D. W. J., Brouillard, D., & Matangi, M. F. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.12.025 · Cited by 13

Prediction Is Difficult, Particularly About the Future

Jackson, R., & Wells, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.21.2286 · Cited by 13

Effect of Aerobic Exercise Training on Serum Levels of High-Density Lipoprotein Cholesterol: A Meta-analysis

Kodama, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.999 · Cited by 5

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437741.48606.98 · Cited by 3,697

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501031 · Cited by 2,296

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

Sabatine, M. S., Giugliano, R. P., Wiviott, S. D., Raal, F. J., Blom, D. J., Robinson, J., Ballantyne, C. M., Somaratne, R., Legg, J., Wasserman, S. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500858 · Cited by 1,509

A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy

Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., Brown, J. P., Cohen, A., & Kim, H. (2013) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-9-30 · Cited by 1,268